These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25640585)

  • 1. Design and synthesis of new substrates of HtrA2 protease.
    Wysocka M; Wojtysiak A; Okońska M; Gruba N; Jarząb M; Wenta T; Lipińska B; Grzywa R; Sieńczyk M; Rolka K; Lesner A
    Anal Biochem; 2015 Apr; 475():44-52. PubMed ID: 25640585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate specificity of human matriptase-2.
    Wysocka M; Gruba N; Miecznikowska A; Popow-Stellmaszyk J; Gütschow M; Stirnberg M; Furtmann N; Bajorath J; Lesner A; Rolka K
    Biochimie; 2014 Feb; 97():121-7. PubMed ID: 24161741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mitochondrial serine protease HtrA2/Omi: an overview.
    Vande Walle L; Lamkanfi M; Vandenabeele P
    Cell Death Differ; 2008 Mar; 15(3):453-60. PubMed ID: 18174901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional analysis of the ligand specificity of the HtrA2/Omi PDZ domain.
    Zhang Y; Appleton BA; Wu P; Wiesmann C; Sidhu SS
    Protein Sci; 2007 Aug; 16(8):1738-50. PubMed ID: 17656586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric regulation of serine protease HtrA2 through novel non-canonical substrate binding pocket.
    Bejugam PR; Kuppili RR; Singh N; Gadewal N; Chaganti LK; Sastry GM; Bose K
    PLoS One; 2013; 8(2):e55416. PubMed ID: 23457469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HtrA proteins as targets in therapy of cancer and other diseases.
    Zurawa-Janicka D; Skorko-Glonek J; Lipinska B
    Expert Opin Ther Targets; 2010 Jul; 14(7):665-79. PubMed ID: 20469960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a novel and specific inhibitor for the pro-apoptotic protease Omi/HtrA2.
    Cilenti L; Lee Y; Hess S; Srinivasula S; Park KM; Junqueira D; Davis H; Bonventre JV; Alnemri ES; Zervos AS
    J Biol Chem; 2003 Mar; 278(13):11489-94. PubMed ID: 12529364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temperature-induced changes of HtrA2(Omi) protease activity and structure.
    Zurawa-Janicka D; Jarzab M; Polit A; Skorko-Glonek J; Lesner A; Gitlin A; Gieldon A; Ciarkowski J; Glaza P; Lubomska A; Lipinska B
    Cell Stress Chaperones; 2013 Jan; 18(1):35-51. PubMed ID: 22851136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi.
    Li W; Srinivasula SM; Chai J; Li P; Wu JW; Zhang Z; Alnemri ES; Shi Y
    Nat Struct Biol; 2002 Jun; 9(6):436-41. PubMed ID: 11967569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra- and intersubunit changes accompanying thermal activation of the HtrA2(Omi) protease homotrimer.
    Jarzab M; Wenta T; Zurawa-Janicka D; Polit A; Gieldon AJ; Wysocka M; Glaza P; Skorko-Glonek J; Ciarkowski J; Lesner A; Lipinska B
    Biochim Biophys Acta; 2016 Mar; 1864(3):283-296. PubMed ID: 26702898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HtrA protease family as therapeutic targets.
    Skorko-Glonek J; Zurawa-Janicka D; Koper T; Jarzab M; Figaj D; Glaza P; Lipinska B
    Curr Pharm Des; 2013; 19(6):977-1009. PubMed ID: 23016688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new function of human HtrA2 as an amyloid-beta oligomerization inhibitor.
    Kooistra J; Milojevic J; Melacini G; Ortega J
    J Alzheimers Dis; 2009; 17(2):281-94. PubMed ID: 19502709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide selectivity between the PDZ domains of human pregnancy-related serine proteases (HtrA1, HtrA2, HtrA3, and HtrA4) can be reshaped by different halogen probes.
    Sun ML; Sun LM; Wang YQ
    J Mol Recognit; 2018 Jun; 31(6):e2698. PubMed ID: 29266444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual regulatory switch confers tighter control on HtrA2 proteolytic activity.
    Singh N; D'Souza A; Cholleti A; Sastry GM; Bose K
    FEBS J; 2014 May; 281(10):2456-70. PubMed ID: 24698088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intricate structural coordination and domain plasticity regulate activity of serine protease HtrA2.
    Chaganti LK; Kuppili RR; Bose K
    FASEB J; 2013 Aug; 27(8):3054-66. PubMed ID: 23608143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of selective substrates of proteinase 3 using combinatorial chemistry methods.
    Wysocka M; Lesner A; Guzow K; Mackiewicz L; Legowska A; Wiczk W; Rolka K
    Anal Biochem; 2008 Jul; 378(2):208-15. PubMed ID: 18445466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate specificity and inhibitory study of human airway trypsin-like protease.
    Wysocka M; Spichalska B; Lesner A; Jaros M; Brzozowski K; Łegowska A; Rolka K
    Bioorg Med Chem; 2010 Aug; 18(15):5504-9. PubMed ID: 20620066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HtrA2/Omi influences the stability of LON protease 1 and prohibitin, proteins involved in mitochondrial homeostasis.
    Goo HG; Rhim H; Kang S
    Exp Cell Res; 2014 Nov; 328(2):456-65. PubMed ID: 25094062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The homotrimeric structure of HtrA2 is indispensable for executing its serine protease activity.
    Nam MK; Seong YM; Park HJ; Choi JY; Kang S; Rhim H
    Exp Mol Med; 2006 Feb; 38(1):36-43. PubMed ID: 16520551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new proteinase 3 substrate with improved selectivity over human neutrophil elastase.
    Popow-Stellmaszyk J; Wysocka M; Lesner A; Korkmaz B; Rolka K
    Anal Biochem; 2013 Nov; 442(1):75-82. PubMed ID: 23911525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.